“Hello Shareholders,
Hopefully, you were encouraged by our FY’23 third quarter OTC filing. That said, we recognize that we have a long way to go to win back your confidence and embrace that challenge.
We will remain focused on improving our financial performance (and the reporting of it), including cash management. We have made major strides in reducing past due receivables and winning back terms with vendors. Invoicing is now current, including royalties. Our QuickBooks accounts are infinitely more accurate than just six months ago.
We will soon hire a new Controller that will focus on the reduction of the company’s operating costs and a resulting gain in operating margin. Additionally, the improvement of our OTC reporting and removal of the company’s yield sign.
New sales and marketing initiatives will drive longer-term revenue and resultant margin growth. We are investing in Google Ad Words and lead generation campaigns. We are refreshing our brand with a new logo and website (coming soon!).
Vital to our success will be a greater investment in R&D initiatives that will widen our product offering and drive sales. To that end, we have added to our R&D bench with the recent hire of a chemist.
Our products continue to outperform the competition, as evidenced by a recent guidewire friction durability test performed by a global leader in medical device manufacturing.
I am grateful to be given this opportunity to run such a wonderful company and one that boasts a legacy brand. I intend on building a high performing and winning culture within the building. Some amount of organizational re-structuring has begun.
We are in the process of finalizing our
Finally, I am anxious to connect with all shareholders and will continue to provide periodic updates. I welcome your feedback. I can be reached at m.torti@hydromer.com."
800-326-5976
M.Torti@hydromer.com
Source:
2023 GlobeNewswire, Inc., source